By Charles Sherwood : Eldorado Gold (NYSE: EGO ) recently reported solid second ..... price of gold. More importantly, Eldorado raised their outlook for 2014. Paul Wright, CEO of Eldorado Gold stated, "Reflecting the strong
Of those Morningstar equity analysts cover, only Eldorado Gold Corp EGO earns the highest Stewardship Rating of Exemplary. Analyst Kristoffer Inton has written that only EGO has an economic moat as it, "boasts lower production
Feb 24 (Reuters) - Eldorado Gold Corp has agreed to sell a minority stake in its Eastern Dragon gold project to Chinese private equity firm CDH Investments, the Canadian miner said on Monday.
After reviewing Eldorado Gold ’s full results, we are maintaining ..... royalties) of $570 to $590 per ounce. Eldorado is forecasting an all-in sustaining ..... 640 per ounce. However, we think Eldorado ’s forecast reduction of sustaining
(Reuters) - Eldorado Gold Corp 's Perama Hill project in Greece is not likely to be approved before local elections scheduled for mid-year, the gold miner said on Thursday.
Eldorado Gold continued to execute through the fourth quarter of 2013, as we have come ..... Environmental Impact Assessment as expected during 2013. Furthermore, Eldorado does not expect approval until after local elections occurring in the
Eldorado Gold continued to make impressive progress ..... fell 20% from the prior-year quarter, Eldorado still saw a 2% growth in revenue to ..... with such a drastic gold price decline. Eldorado remains a low-cost gold producer and
growth over as long a period. Of those the Morningstar equity analysts cover, only Randgold Resources GOLD and Eldorado Gold Corp ELD earn the highest Stewardship Rating of Excellent. Analyst Joung Park has written that only ELD has an economic
Eldorado Gold EGO reported impressive second-quarter ..... operations in the new price environment, Eldorado increased revenue by 9% to $267 million ..... the industry curve, which should help Eldorado continue to generate returns despite
Oracle ORCL Wide -9.1% Microsoft MSFT Wide -1.0% Gilead Sciences GILD Narrow -5.9% Pfizer PFE Wide 2.9% Eldorado Gold EGO Narrow -22.5% Exelon EXC Wide -1.5% Wells Fargo WFC Narrow 1.8% Berkshire Hathaway BRK.B Wide -1